MENU
ILMN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Illumina (ILMN) Ownership - Who owns Illumina?
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
5200 Illumina Way
Phone
+1 858 202-4500
Employees
10670
Web
https://www.illumina.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
21.09B
P/E Ratio
49.50
Total Cash
1.05B
Projected Growth
4.30
Total Debt
2.26B
Revenue
4.5B
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash/Share
6.63
Total Debt/Equity
53.89
Revenue/Share
28.51 USD as % of share price
Fundamentals
ILMN
Capitalization
21.1B
P/E Ratio
49.50
Risk (Beta)
1.50
Dividend Yield
N/A
Total Cash
1.05B
Total Cash/Share
6.63
Total Debt
2.26B
Total Debt/Equity
53.89
Projected Growth (PEG Ratio)
4.30
Revenue/Share (as % of the share price)
28.51%
Revenue
4.5B
ROE
N/A
Book Value
5.75B
P/B Ratio
3.67
Cash Flow
N/A
Earnings
-7.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2M
Current Ratio
1.66
Current Revenue Per Employee
120645.16
Dividends Per Share - Security
N/A
EBITDA
-608M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.07
Revenue To Assets
-10.38
Shares Held By Institutions
51B
Shares Outstanding - Current
159M
Total Liabilities
4.37B
Total Volume MTD
N/A
Value
-1
Gain YTD
-40.627
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of integrated systems for the analysis of genetic variation and function
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Biotechnology
Address
5200 Illumina Way
Phone
+1 858 202-4500
Employees
10670
Web
https://www.illumina.com